`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC,
`
`Petitioner
`
`V.
`
`QUALICAPS CO., LTD,
`Patent Owner
`
`Case IPR2017-00203
`
`Patent 6,649,180
`
`PATENT OWNER’S UNOPPOSED MOTION FOR ADMISSION
`
`PRO HAC VICE OF MICHAEL N. KENNEDY UNDER 37 C.F.R. § 42.10
`
`DC: 04285544
`
`
`
`I'PR2017-00203
`
`1.
`
`Relief Requested
`
`Pursuant to 37 C.F.R. § 42.10, and in accordance with the Board’s Order,
`
`Paper No. 7 in Case iPR2013-00639, and the Notice of Filing Date Accorded to
`
`Petition (Paper No. 3), Patent Owner requests that the Board admit Michael N.
`
`Kennedy pro lmc vice in this proceeding. Counsei for Petitioner has informed the
`
`undersigned that Petitioner does not oppose this motion.
`
`II.
`
`Statement of Facts
`
`37 C.F.R. §42.10(c) states that the Board “may recognize counsel pro hac
`
`vice during a proceeding upon a showing of good cause, subject to the condition
`
`that lead counsel be a registered practitioner and to any other conditions as the
`
`Board may impose. For exampie, where the lead counsei
`
`is
`
`a
`
`registered
`
`practitioner, a motion to appear pro hac vice by counsel who is not a registered
`
`practitioner may be granted upon showing that counsel is an experienced litigating
`
`attorney and has an established familiarity with the subject matter at issue in the
`
`proceeding.” The facts, supported by the attached Declaration of Michael N.
`
`Kennedy in Support of Patent Owner’s Motion for Admission Pro Hac Vice
`
`(“Kennedy Declaration”), establish good cause to admit Mr. Kennedy pro hac vice
`
`in this proceeding.
`
`1.
`
`Lead counsel, Jessica L. Parezo, is a registered practitioner.
`
`
`
`IPR2017-00203
`
`2.
`
`Counsei, Michael N. Kennedy, is an experienced litigating attorney
`
`with over ten years in private iaw practice. Kennedy Decl. at it 9. Mr. Kennedy has
`
`substantial experience with bench trials, jury trials, and Markman hearings and has
`
`been counsei in over twenty patent infringement matters. Id. Mr. Kennedy is a
`
`member in good standing of the New York State Bar and the District of Columbia
`
`Bar. Id. at it 2. He is also admitted to practice in the United States District Court for
`
`the Southern District of New York, United States Court of Appeals for the Federal
`
`Circuit, and United States Court of Appeals for the Eleventh Circuit. Id. He has no
`
`suspensions or disbarments from practice, nor any application for admission to
`
`practice denied, nor any sanctions or contempt citations. Id. at 'li‘ll 36.
`
`3.
`
`Mr. Kennedy was admitted to practice before this Board pro hac vice
`
`in 1PR2015-01776,
`
`IPR2015-01780, and IPR2015-01785. See Coalition for
`
`Afiordable Drugs X, LLC v. Anacor Pharms., Inc, IPR2015~01776, IPR2015-
`
`01780, and IPR2015»01785, Paper No. 42 (P.T.A.B. June 29, 2016); Kennedy
`
`Decl. at it 8. Mr. Kennedy was also admitted to practice before this Board pro hac
`
`vice in IPR2016-00458. See Eli Lilly and Company v. The Trustees of The
`
`University of Pennsylvania,
`
`IPR2016—00458, Paper No. 28 (P.T.A.B. Nov. 8,
`
`2016); Kennedy Deci. at ll 8.
`
`4.
`
`Mr. Kennedy has familiarity with the subject matter and patent at
`
`issue in this proceeding, US. Patent No. 6,649,180 (“the ’180 Patent”), including
`
`
`
`IPR2017-00203
`
`its prosecution history and the scientific field to which the ’180 Patent
`
`is
`
`addressed. Kennedy DecI. at ii 10. Mr. Kennedy is one of the counsel of record for
`
`Patent Owner in co-pending district court litigation concerning the "180 Patent. His
`
`extensive involvement in. the (Io—pending litigation required developing a thorough
`
`understanding of the patent at
`
`issue in this proceeding,
`
`the prior art, and the
`
`relevant scientific field. [(1.
`
`In August 2016, he presented argument for Patent
`
`Owner at the Markman hearing in the district court litigation. Id.
`
`5.
`
`Mr. Kennedy has read and will compiy with the Office Patent Triai
`
`Guide and the Board’s Rules for Practices for Trials set forth in Part 42 of the
`
`C.F.R., and he agrees to be subject to the USPTO Rules of Professional Conduct
`
`set forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary jurisdiction under 37
`
`CPR. § 11.19(a).1d. at it'll 6-7.
`
`III. Anaiysis
`
`The facts contained in the Statement of Facts above, and contained in the
`
`Kennedy Declaration, establish that there is good cause to admit Mr. Kennedy pro
`
`hac vice in this proceeding, under 37 CER. § 42.10. Lead counsel is a registered
`
`practitioner, Mr. Kennedy is an experienced litigating attorney, and Mr. Kennedy
`
`has an established familiarity with the subject matter at issue in this proceeding.
`
`
`
`IPR2017-00203
`
`IV. Conclusion
`
`For the foregoing reasons, Patent Owner respectfully requests that the Board
`
`admit Michael N. Kennedy pro hac vice in this proceeding.
`
`Date: May 31, 201.7
`
`Andrea G. Rerster
`
`Registration No.: 36,253
`Scott E. Kamholz
`
`Registration No.: 48,543
`COVINGTGN & BURLING LLP
`
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`
`MaryAnne Armstrong
`Registration No.: 40,069
`Lynde F. Herzbach
`Registration No.: 74,886
`BIRCH, STEWART, KOLASCI—I & BIRCH, LLP
`
`8110 Gatehouse Road, Suite 100 East
`
`Falls Church, VA 22042
`(703) 205-8000
`
`Attorneys for Patent Owner
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 3‘ist day of May
`
`2017, the foregoing Patent Owner’s Unopposed Motion for Admission Pro Han
`
`Vice of Michael. N. Kennedy Under 37 CER. § 42.10 was served by electronic
`
`mail, by agreement of the parties, on the following counsel of record for Petitioner.
`
`Mitchell G. Stockwell
`
`David C. Holloway
`Jonathan I). Clinger
`Miranda C. Rogers
`Mylan-WC-IPR@kilpatricktownsend.com
`Kilpatrick Townsend & Stockton LLP
`
`Date: May 31, 2017
`
`